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mTORProlonged caloric restriction often results in alteration in heart geometry and function although the underlying
mechanism remains poorly deﬁned. Autophagy, a conserved pathway for bulk degradation of intracellular
proteins and organelles, preserves energy and nutrient in the face of caloric insufﬁciency. This study was
designed to examine the role of AMPK in prolonged caloric restriction-induced change in cardiac homeostasis
and the underlying mechanism(s) involved with a focus on autophagy. Wild-type (WT) and AMPK kinase
dead (KD) mice were caloric restricted (by 40%) for 30 weeks. Echocardiographic, cardiomyocyte contractile
and intracellular Ca2+ properties, autophagy and autophagy regulatory proteins were evaluated. Caloric restric-
tion compromised echocardiographic indices (decreased ventricularmass, left ventricular diameters, and cardiac
output), cardiomyocyte contractile and intracellular Ca2+ properties associated with upregulated autophagy
(Beclin-1, Atg5 and LC3BII-to-LC3BI ratio), increased autophagy adaptor protein p62, elevated phosphorylation
of AMPK and TSC1/2, depressed phosphorylation of mTOR and ULK1. Although AMPK inhibition did not affect
cardiac mechanical function, autophagy and autophagy signaling proteins, it signiﬁcantly accentuated caloric
restriction-induced changes in myocardial contractile function and intracellular Ca2+ handling. Interestingly,
AMPK inhibition reversed caloric restriction-induced changes in autophagy and autophagy signaling. AMPK inhi-
bition led to dampened levels of Beclin-1, Atg 5 and LC3B ratio along with suppressed phosphorylation of AMPK
and TSC1/2 as well as elevated phosphorylation of mTOR and ULK1. Taken together, these data suggest an
indispensible role for AMPK in the maintenance of cardiac homeostasis under prolonged caloric restriction-
induced pathological changes possibly through autophagy regulation. This article is part of a Special Issue entitled:
Autophagy and protein quality control in cardiometabolic diseases.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Effective regulation of energy metabolism such as calorie restriction
is known to offer health beneﬁts such as prolonging lifespan, reducing
the overall disease morbidity andmortality [1]. A plethora of cardiovas-
cular beneﬁts have been conﬁrmed for caloric restriction including
improvement of endothelial function, arterial stiffness, atherogenesis,
myocardial interstitial ﬁbrosis, cardiac apoptosis, oxidative stress,
inﬂammation and ventricular diastolic function [1–4]. Nonetheless,y and protein quality control in
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hang).disturbances of the energy balance such as prolonged caloric restriction
jeopardize human health and provoke unfavorablymyocardial sequelae
[5–7]. Although scenarios such as loss of ATP and energy supply may
play a role in prolonged caloric restriction-induced cardiac anomalies
[3], themechanisms behindprolonged caloric restriction-induced cardi-
ac geometric and functional changes remain somewhat elusive. Recent
ﬁnding fromour group depicted a rather important role for the essential
housekeeping mechanism – autophagocytosis of damaged structures
(a.k.a. autophagy) in the maintenance of cardiac homeostasis in the
face of caloric restriction [8–10].
The autophagy-lysosome pathway is a conservative pathway re-
sponsible for protein and organelle degradation and recycling [11,12].
Autophagy plays an essential role in the regulation of cardiac homeosta-
sis and may be prone to a number of pathological insults including
ischemia–reperfusion, cardiac hypertrophy and heart failure [12–14].
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resulted from pressure overload and ischemia–reperfusion injury
[15–17]. On the other hand, suppression of autophagy may counteract
cardiac hypertrophy, ER stress-induced and alcoholic cardiomyopathy
[18–20]. Among the various physiological and pharmacological regula-
tors of autophagy, caloric restriction serves as perhaps the most potent
inducer for autophagy [8,21]. In the face of nutrient stress (insufﬁcien-
cy), autophagy is initiated tomaintain intracellular ATP and cell survival
through degrading and recycling membrane lipids, intracellular
proteins and organelles [22]. Disruption of autophagy using lysosomal
inhibition has been shown to initiate cardiac functional anomalies
under food restriction [9]. AMPK, which is highly expressed in the
heart, functions as themost signiﬁcant signalingmolecule to govern au-
tophagy. Activated AMPK by an increase in the cellular AMP/ATP ratio
promotes autophagy to turn on the energy producing processes while
shutting down the energy consuming processes [11]. Not surprisingly,
caloric restriction promotes AMPK activation whereas nutritional sur-
plus inhibits AMPK activity and concurrently triggers insulin resistance,
contributing to the onset and progression of metabolic syndrome [23].
Given the pivotal role of the cellular fuel AMPK in cardiac homeostasis,
this study was designed to examine the role of AMPK in the prolonged
caloric restriction-induced changes in cardiac geometric and functional
homeostasis, if any. Emerging evidence has demonstrated that AMPK
regulates not only energy metabolism but also essential housekeeping
mechanisms such as autophagocytosis of damaged structures under
pathological stress conditions including starvation [23–25]. To this
end, levels of the autophagy proteins Beclin-1, Atg5 and LC3B as well
as the autophagosome cargo protein p62 were evaluated. Intracellular
Ca2+ regulatory proteins and the autophagy regulatory cascades includ-
ing AMPK, and the AMPK downstream signal molecules including
tumor suppress gene tuberous sclerosis complex (TSC), mTOR and
unc-51-like kinase (ULK1) [22] were evaluated in hearts from wild
type (WT) and AMPK kinase dead (KD) mice following prolonged
caloric restriction.
2. Materials and methods
2.1. Experimental animals
The experimental procedure described in this study was approved
by our Institutional Animal Use and Care Committee (University of
Wyoming, Laramie, WY) and was in compliance with the Guide for the
Care and Use of Laboratory Animals published by the National Institutes
of Health (NIH publication no. 85-23, revised 1996). TheAMPK transgen-
ic mice overexpress a dominant negative α2 subunit of AMPK (kinase
dead, KD, K45R mutation, KD1 line) driven by a muscle speciﬁc creatine
kinase promoter to the skeletal and cardiac muscles were obtained from
Dr. Morris Birnbaum (University of Pennsylvania, Philadelphia, PA) [26,
27]. Littermates expressing wild type of α2 subunit of AMPK were used
as the control. Due to the replacement of functional α1, α2 and α3 iso-
forms by the KD α2 isoform, KD mice display very low AMPK activity
in skeletal and cardiac muscles. Genotyping was done by using PCR. In
brief, 4-month-old adult male C57BL/6 wild type (WT) and AMPKKD
mice were housed in individual cages and were fed ad libitum for
2 weeks. Mice were then randomly divided into ad libitum control and
caloric restriction groups. Control mice were fed ad libitum for the next
30 weeks whereas caloric restriction mice received 90% of the average
value of calorie for 1 week (10% restriction for acclimation) followed
by 60% of calorie for 29 weeks (40% restriction) [7]. The diet (28.5%,
13.4% and 58.0% calorie from protein, fat and carbohydrate, respectively,
catalog 5001, LabDiet, St. Louis, MO) was enriched in vitamins and
minerals to ensure constant daily intake of vitamins andminerals during
the caloric restriction period. Levels of blood glucose and insulin were
measured by using an Accu-Chek III glucose analyzer (Accu-CheckII,
model 792; Boehringer Mannheim Diagnostics, Indianapolis, IN) and
an insulin enzyme-linked immunosorbent assay kit (Linco Research St.Charles, MO), respectively. Systolic, diastolic and mean blood pressures
were examined by using a KODA semi-automated, ampliﬁed tail cuff
device (Kent Scientiﬁc Corporation, Torrington, CT) [28].
2.2. Intraperitoneal glucose tolerance test (IPGTT)
Prior to sacriﬁce, mice were fast for 12 h and were then given an in-
traperitoneal (i.p.) injection of glucose (2 g/kg body weight). Blood
samples were drawn from the tail vein immediately before glucose
challenge, as well as 15, 60, 90 and 120 min thereafter. Blood glucose
levels were determined by using an Accu-Chek glucose analyzer. The
area under the curve (AUC)was calculated by using trapezoidal analysis
for each adjacent time point and serum glucose level [28].
2.3. Body fat composition measurement
Body composition was measured by using Dual Energy X-ray
Absorptiometry (DEXA), which is a clinical measure of lean tissue
mass, adipose tissue mass, and bone mineral mass and density. A low
level pencil-beam x-ray moved transversely from the head to the tail
across the sedated mouse. Difference in absorbance of the X-ray was
detected according to tissue density. Percent fat was calculated by
using fat and body mass [29].
2.4. Measurement of physical activity
To measure physical activity over a period of 24 h, mice housed indi-
vidually were positioned in an automated open-ﬁeld activity monitor
using digital counters with an infrared sensor (CLAMS, Columbus, OH)
[30].
2.5. Echocardiographic assessment
Cardiac geometry and function were evaluated in anesthetized (keta-
mine 80 mg/kg and xylazine 12 mg/kg, i.p.) mice by using the two-
dimensional guided M-mode echocardiography (Philips SONOS 5500)
equipped with a 15–6 MHz linear transducer (Phillips Medical Systems,
Andover,MD). The chestswere shaved andmicewere placed in a shallow
left lateral position on a heating pad. Using the 2-dimensional (2D)
parasternal short-axis image obtained at a level close to papillarymuscles
as a guide, a 2D guidedM-mode trace crossing the anterior and posterior
wall of the LV was obtained. The echocardiographer was blind to the
treatment of themice. Left ventricular (LV) anterior and posteriorwall di-
mensions during diastole and systole were recorded from three consecu-
tive cycles inM-modeusing amethod adopted by theAmerican Society of
Echocardiography. Fractional shortening was calculated from LV end-
diastolic (EDD) and end-systolic (ESD) diameters using the equation
(EDD–ESD)/EDD*100. Estimated echocardiographically-derived LV mass
was calculated as [(LVEDD + septal wall thickness + posterior wall
thickness)3 – LVEDD3] × 1.055, where 1.055 (mg/mm3) denotes the den-
sity ofmyocardium.Heart rateswere averaged over 10 consecutive cycles
[30].
2.6. Isolation of murine cardiomyocytes
Hearts were rapidly removed from anesthetized mice and mounted
onto a temperature-controlled (37 °C) Langendorff system. After perfu-
sion with a modiﬁed Tyrode's solution (Ca2+ free) for 2 min, the heart
was digested with a Ca2+-free KHB buffer containing liberase
blendzyme 4 (Hoffmann-La Roche Inc., Indianapolis, IN) for 20 min.
The modiﬁed Tyrode solution (pH 7.4) contained the following (in
mM): NaCl 135, KCl 4.0, MgCl2 1.0, HEPES 10, NaH2PO4 0.33, glucose
10, butanedione monoxime 10, and the solution was gassed with 5%
CO2–95% O2. The digested heart was then removed from the cannula
and left ventricle was cut into small pieces in the modiﬁed Tyrode's so-
lution. Tissue pieces were gently agitated and pellet of cells was
Table 1
Biometric and echocardiographic parameters of WT and AMPK knockout (KO) mice with or without the 30-week caloric restriction (CR).
Parameter WT WT-CR AMPKKO AMPKKO-CR
Body weight (g) 26.4 ± 0.7 23.3 ± 0.3* 26.2 ± 0.8 23.3 ± 0.3*
Heart weight (mg) 147 ± 2 130 ± 3* 144 ± 4 120 ± 2*,#
Heart/body weight (mg/g) 5.63 ± 0.19 5.61 ± 0.13 5.50 ± 0.06 5.13 ± 0.10*
Diastolic blood pressure (mmHg) 73.4 ± 4.2 75.2 ± 3.3 76.5 ± 1.3 72.3 ± 3.7
Systolic blood pressure (mmHg) 100.8 ± 3.7 100.6 ± 3.6 106.4 ± 2.0 100.6 ± 3.7
Mean blood pressure (mmHg) 82.2 ± 4.0 83.5 ± 3.3 85.3 ± 1.5 80.5 ± 3.4
Blood glucose level (mg/dl) 111 ± 2 118 ± 9 107 ± 4 104 ± 13
Blood glucose level (ng/ml) 0.368 ± 0.045 0.404 ± 0.047 0.390 ± 0.059 0.370 ± 0.056
Myocardial ATP levels (pmol/mg) 65.4 ± 5.9 48.6 ± 4.9* 59.6 ± 6.9 37.4 ± 4.2*,#
Heart rate (bpm) 534 ± 24 530 ± 18 514 ± 26 508 ± 19
LV wall thickness (mm) 1.13 ± 0.05 1.04 ± 0.02* 1.07 ± 0.05 1.10 ± 0.06
LV septal thickness (mm) 1.24 ± 0.06 1.09 ± 0.05* 1.18 ± 0.05 1.16 ± 0.04
LV ESD (mm) 1.17 ± 0.06 1.09 ± 0.04 1.11 ± 0.10 1.27 ± 0.05
LV EDD (mm) 2.31 ± 0.06 2.19 ± 0.07* 2.36 ± 0.15 2.00 ± 0.08*,#
Calculated LV mass (mg) 47.1 ± 2.7 39.7 ± 1.6* 40.8 ± 6.1 31.8 ± 2.5*,#
Normalized LV mass (mg/g) 1.83 ± 0.11 1.71 ± 0.06 1.55 ± 0.22 1.36 ± 0.10*,#
Factional shortening (%) 49.7 ± 1.5 49.8 ± 2.2 53.3 ± 3.0 36.6 ± 2.0*,#
Cardiac output (mm3*min) 5876 ± 648 4923 ± 514* 6268 ± 1028 3137 ± 394*,#
LV: left ventricular; LV ESD: LV end systolic diameter; LV EDD: LV end diastolic diameter; Mean ± SEM, n = 8 mice per group, * p b 0.05 vs. WT group, # p b 0.05 vs. WT-CR group.
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1.20 mM over 30 min. A yield of at least 60–70% viable rod-shaped
cardiomyocytes with clear sarcomere striations was achieved. Neither
caloric restriction nor AMPK deﬁciency overtly affected cardiomyocyte
yield. Only rod-shaped myocytes with clear edges were selected for
contractile and intracellular Ca2+ studies [28].
2.7. Cell shortening/relengthening
Mechanical properties of cardiomyocytes were assessed by using a
SoftEdgeMyoCam® system (IonOptix Corporation,Milton,MA). IonOptixFig. 1. Intraperitoneal glucose tolerance test (IPGTT, 2 g/kg bodyweight), body fat composition
curve depicting glucose clearance capacity; B: Area underneath the curve plotted (AUC) in pane
an infrared sensor. Mean ± SEM, n = 6–7 mice per group, * p b 0.05 vs. WT group.SoftEdge software was used to capture changes in cardiomyocyte length
during shortening and relengthening. In brief, cardiomyocytes were
placed in aWarner chamber mounted on the stage of an inverted micro-
scope (Olympus, IX-70) and superfused (1 ml/min at 25 °C)with a buffer
containing (in mM): 131 NaCl, 4 KCl, 1 CaCl2, 1 MgCl2, 10 glucose, 10
HEPES, at pH 7.4. The cells were ﬁeld stimulated with supra-threshold
voltage at a frequency of 0.5 Hz (unless otherwise stated), 3 ms duration,
using a pair of platinum wires placed on opposite sides of the chamber
connected to a FHC stimulator (Brunswick, NE). Themyocyte being stud-
ied was displayed on the computer monitor using an IonOptix MyoCam
camera. IonOptix SoftEdge software was used to capture changes in celland physical activity in control or caloric restricted (CR)WT and AMPK KDmice. A: IPGTT
l A; C: Body fat compositionmeasured using DEXA; andD: Physical activitymeasured using
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relengthening were assessed by using the following indices: peak short-
ening (PS) – the amplitudemyocytes shortened on electrical stimulation,
which is indicative of peak ventricular contractility; time-to-PS (TPS) –
the duration of myocyte shortening, which is indicative of contraction
duration; time-to-90% relengthening (TR90) – the duration to reach 90%
re-lengthening, which represents cardiomyocyte relaxation duration
(90% rather 100% relengtheningwas used to avoid noisy signal at baseline
concentration); and maximal velocities of shortening (+dL/dt) and
relengthening (−dL/dt) –maximal slope (derivative) of shortening and
relengthening phases, which are indicatives of maximal velocities of
ventricular pressure rise/fall. In the case of altering stimulus frequency
from 0.1 to 5.0 Hz, the steady state contraction of myocyte was achieved
(usually after the ﬁrst 5–6 beats) before PS was recorded [28].2.8. Intracellular Ca2+ transient measurement
Myocytes were loaded with fura-2/AM (0.5 μM) for 10 min and
ﬂuorescence measurements were recorded with a dual-excitationFig. 2. Cardiomyocyte contractile function in control or caloric restricted (CR) WT and AMPK
velocity of relengthening (−dL/dt); D: Peak shortening (PS, normalized to resting cell length
cells from 4 mice per group, *p b 0.05 vs. WT group, # p b 0.05 vs. WT-CR group.ﬂuorescence photomultiplier system (IonOptix). Cardiomyocytes were
placed on an Olympus IX-70 inverted microscope and imaged through a
Fluor × 40 oil objective. Cells were exposed to light emitted by a 75 W
lamp and passed through either a 360 or a 380 nm ﬁlter, while being
stimulated to contract at 0.5 Hz. Fluorescence emissions were detected
between 480 and 520 nm by a photomultiplier tube after ﬁrst illuminat-
ing the cells at 360 nm for 0.5 s then at 380 nm for the duration of the
recording protocol (333 Hz sampling rate). The 360 nm excitation scan
was repeated at the end of the protocol and qualitative changes in intra-
cellular Ca2+ concentrationwere inferred from the ratio of fura-2 ﬂuores-
cence intensity (FFI) at two wavelengths (360/380). Fluorescence decay
time was measured as an indication of the intracellular Ca2+ clearing
rate. Both single and biexponential curve ﬁt programs were applied to
calculate the intracellular Ca2+ decay constant [28].2.9. Western blot analysis
Expression of the essential autophagic markers Beclin-1, Atg 7, p62
and LC3B, the autophagy regulatory proteins AMPK, Akt, TSC2, mTORKD mice. A: Resting cell length; B: Maximal velocity of shortening (+dL/dt); C: Maximal
); E: Time-to-PS (TPS); and F: Time-to-90% relengthening (TR90). Mean ± SEM, n = 115
Fig. 3. Intracellular Ca2+ transient properties in cardiomyocytes from control or caloric restricted (CR)WT andAMPKKDmice. A: Resting fura-2ﬂuorescence intensity (FFI); B: Electrically-
stimulated rise in FFI (ΔFFI); C: Single exponential intracellular Ca2+ decay rate; and D: Biexponential intracellular Ca2+ decay rate. Mean ± SEM, n = 76 cells from 4 mice per group,
*p b 0.05 vs. WT group, # p b 0.05 vs. WT-CR group.
Fig. 4. Changes of cell length and peak shortening (PS) amplitude in cardiomyocytes from
control or caloric restricted (CR) WT and AMPK KDmice. A. Resting cell length at various
stimulus frequencies (0.1–5.0Hz); andB: PS at various stimulus frequencies normalized to
that obtained at 0.1 Hz from the same cell. Mean± SEM, n= 23–30 cells from 4mice per
group, *p b 0.05 vs. WT group, # p b 0.05 vs. WT-CR group.
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equal amount of proteins were separated on 10% SDS-polyacrylamide
gels in a minigel apparatus (Mini-PROTEAN II, Bio-Rad) and transferred
to nitrocellulose membranes. The membranes were blocked with
5% milk in TBS-T, and were incubated overnight at 4 °C with anti-
SERCA2a (1:1000), anti-phospholamban (1:1000), anti-Na+-Ca2+
exchanger (1:1000), anti-AS160 (1:1000), anti-Beclin-1 (1:1000),
anti-Atg5 (1:1000), anti-p62 (1:1000), anti-LC3B (1:1000), anti-p62/
SQSTM1 (1:1000), anti-TSC2 (1:1000), anti-phosphorylated TSC2
(Ser939, 1:1000), anti-AMPK (1:1000), anti-pAMPK (Thr172, 1:1000),
anti-mTOR (1:1000), anti-phosphorylated mTOR (Ser2448, 1:1000),
anti-ULK1 (1:1000) and anti-phosphorylated ULK1 (Ser757, 1:1000) an-
tibodies. All antibodies were obtained from Cell Signaling Technology
(Beverly, MA) or Santa Cruz (Santa Cruz, CA). After immunoblotting,
the ﬁlm was scanned and the intensity of immunoblot bands was
detected with a Bio-Rad Calibrated Densitometer. GAPDH was used as
the loading control.
2.10. Data analysis
Data were expressed as Mean ± SEM. Statistical signiﬁcance
(p b 0.05) was estimated by one-way analysis of variation
(ANOVA) followed by a Tukey's test for post hoc analysis or 2-
way repeated-measures of ANOVA (for IPGTT). All statistics was per-
formed with GraphPad Prism 4.0 software (GraphPad, San Diego, CA).
3. Results
3.1. General biometric and echocardiographic properties of WT and
AMPKDD mice
As expected, prolonged caloric restriction signiﬁcantly reduced body
and heart weights but not heart size (normalized to body weight).
AMPK kinase dead itself did not affect body or heart weights (or size)
although it signiﬁcantly accentuated caloric restriction-induced loss of
337Q. Zheng et al. / Biochimica et Biophysica Acta 1852 (2015) 332–342cardiac mass (but not body weight). Neither caloric restriction nor
AMPK inhibition affected levels of blood glucose, blood insulin, systolic,
diastolic and mean blood pressure. Prolonged caloric restriction overtly
decreased LV wall thickness, septal thickness, LVEDD, LV mass and car-
diac output without affecting LVESD, normalized LVmass and fractional
shortening, the effects of which were signiﬁcantly accentuated or
unmasked by AMPK inhibition. AMPK inhibition itself did not elicit
any effects on these echocardiographic indices. Caloric restriction sled
to a signiﬁcant loss of myocardial ATP levels, the effect of which was
augmented by AMPK inhibition with little effect from AMPK inhibition
itself. Heart rate was comparable among all groups (Table 1). These
ﬁndings suggest that AMPK inhibition through kinase dead expression
worsened caloric restriction-induced cardiac remodeling and change
in cardiac function. To assess the status of glucose tolerance, IPGTT
was performed. As shown in Fig. 1A, blood glucose levels were overtly
lower at 15, 60, 90 and 120 min following glucose challenge in caloric
restricted mice compared with control mice regardless of AMPK status.
This is supported by the area under the glucose curve with an overtFig. 5. Expression of intracellular Ca2+ and glucose transport regulatory proteins in hearts
blots depicting levels of SERCA2a, NCX, phospholamban, AS160 and GAPDH (used as the lo
E: Na+–Ca2+ exchanger (NCX); and F: AS160. Insets: Mean ± SEM, n = 6–7 mice per group, *decrease in the caloric restricted WT and AMPKKD groups compared
with controls (Fig. 1B). Our data further revealed that caloric restriction
reduced body fat composition, the effect of which was unaffected by
AMPK inhibition. AMPK inhibition itself did not impose any effect on
body fat composition. Neither caloric restriction nor AMPK inhibition
altered the level of physical activity (Fig. 1C, D).
3.2. Effect of AMPK inhibition on cardiomyocyte contractile and intracellular
Ca2+ responses following caloric restriction
Prolonged caloric restriction led to altered cardiomyocyte contractile
properties including peak shortening, maximal velocity of shortening/
relengthening (±dL/dt), and time-to-90% relengthening (TR90) with-
out affecting resting cell length and time-to-peak shortening (TPS).
AMPK inhibition itself did not affect cardiomyocytemechanical function
although it accentuated caloric restriction-induced cardiomyocyte me-
chanical dysfunction (Fig. 2). To evaluate the possible mechanisms be-
hind chronic caloric restriction- and AMPK deﬁciency-induced cardiacfrom control or caloric restricted (CR) WT and AMPK KD mice. A: Representative gel
ading control); B: SERCA2a; C: Phospholamban; D: SERCA2a-to-phospholamban ratio;
p b 0.05 vs. WT group, # p b 0.05 vs. WT-CR group.
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using the fura-2 ﬂuorescence technique. Our data shown in Fig. 3 re-
vealed that caloric restriction decreased peak and electrical stimulus-
induced rise in intracellular Ca2+ as well as prolonged intracellular
Ca2+ clearance (higher decay rate value) without affecting resting
intracellular Ca2+ levels, the effects of which were accentuated by
AMPK inhibition (except peak intracellular Ca2+). AMPK inhibition it-
self failed to elicit any notable effect on intracellular Ca2+ handling
properties. These data suggested that AMPK inhibition may aggravate
intracellular Ca2+ mishandling following prolonged caloric restriction.
3.3. Effect of AMPK inhibition on stimulus frequency-shortening response in
caloric restriction
Rodent hearts contract at very high frequencies (300–400 beats per
minute), whereas our mechanical assessment was performed at 0.5 Hz.
To evaluate the impact of AMPK inhibition and caloric restriction on car-
diac contractile function at higher frequencies, the stimulus frequency
was increased up to 5.0 Hz (300 beats permin) and recorded the steady
state peak shortening. Cardiomyocytes were initially stimulated to
contract at 0.5 Hz for 5min to ensure a steady state before commencingFig. 6. Expression of autophagicmarkers in hearts from control or caloric restricted (CR)WT and
and Rheb expression. GAPDHwas used as the loading control; B: Beclin-1; C: Atg5; D: LC3B II-to-
WT group, # p b 0.05 vs. WT-CR group.the frequency response. Fig. 4 exhibited a negative staircase of peak
shortening with the increased stimulus frequency in all groups with a
more pronounced decline in caloric restriction group. AMPK inhibition
did not affect the stimulus frequency–shortening response regardless
of the nutrient status.
3.4. Effect of AMPK inhibition on caloric restriction-induced changes in
intracellular Ca2+ regulatory proteins
To further discern themechanism of action responsible for AMPK in-
hibition and caloric restriction-induced changes in intracellular Ca2+
handling, the intracellular Ca2+ regulatory proteins SERCA, the SERCA
inhibitory protein phospholamban, Na+–Ca2+ exchanger and the
glucose uptake regulatory protein AS160 were evaluated. Our result
suggested signiﬁcantly dampened SERCA2a expression andupregulated
phospholamban levels (along with the reduced SERCA2a-to-
phospholamban ratio) in conjunction with unchanged Na+–Ca2+
exchanger and AS160 following caloric restriction, the effect of which
was accentuated by AMPK inhibition. AMPK inhibition itself did not
exert any notable effect on these intracellular Ca2+ or glucose uptake
regulatory proteins (Fig. 5).AMPKKDmice. A: Representative gel blots depicting levels of Beclin-1, Atg5, LC3BI/II, p62
LC3B I ratio; E: p62; and F: Rheb. Insets:Mean±SEM, n=6–7miceper group, *pb 0.05 vs.
339Q. Zheng et al. / Biochimica et Biophysica Acta 1852 (2015) 332–3423.5. Effect of AMPK inhibition on caloric restriction-induced cardiac
autophagy activation
Given the pivotal role of autophagy in the maintenance of cardiac
geometry and function in caloric and food restriction [5,9], the role of
autophagy in caloric restriction-induced cardiac anomalieswas evaluat-
ed. Our data revealed upregulated levels of Beclin-1, Atg5 and LC3BII-to-
LC3BI ratio (a widely accepted protein marker for autophagosome
formation) [31] following caloric restriction, the effect of which was
reversed by AMPK inhibition to levels signiﬁcantly lower than those
from the WT group. Since increased autophagosome formation may
result from increased autophagosome formation (a.k.a. – autophagy ini-
tiation) or interrupted autophagosome degradation (autophagosome
clearance), levels of p62, a well-deﬁned autophagy adaptor preferen-
tially degraded by autophagosomes [32,33], were monitored. Our re-
sults indicated that levels of p62 and Rheb (a small GTP-binding
protein that directly activates mTOR complex 1), were signiﬁcantlyFig. 7. Levels of autophagy regulatory cell signalingmolecules AMPK and TSC2 in hearts from co
TSC2; C–D: PhosphorylatedAMPK and TSC2; and E–F: Ratios of phosphorylated to total forms of
of AMPKα and TSC2. GAPDH was used as the loading control. Mean ± SEM, n = 6–7 mice perupregulated and downregulated, respectively, by prolonged caloric re-
striction, the effect of which was unaffected by AMPK inhibition.
AMPK inhibition itself did not affect the levels of these autophagy
protein markers (Fig. 6).
We further examined the autophagy regulatorymolecules including
AMPK, TSC2, mTOR and ULK1. Our data revealed that sustained caloric
restriction signiﬁcantly promoted phosphorylation of AMPK and the
AMPK downstream target TSC2 without affecting protein expression
of AMPK and TSC2. To the contrary, prolonged caloric restriction signif-
icantly suppressed phosphorylation of mTOR and ULK1 without affect-
ing total protein expression of mTOR and ULK1. Interestingly, AMPK
inhibition using overexpression of dominant negative α2 subunit of
AMPK reversed caloric restriction-induced changes in the phosphoryla-
tion status of AMPK, TSC2, mTOR and ULK1 without affecting total
protein expression of TSC2, mTOR and ULK1. Levels of total AMPK
expressionwere signiﬁcantly higher in AMPK KD groups due to overex-
pression of dominant negative α2 subunit of AMPK (Figs. 7 and 8).ntrol or caloric restricted (CR)WT and AMPK KDmice. A–B: Total expression of AMPK and
AMPK and TSC2. Insets: Representative gel blots depicting total and phosphorylated levels
group, *p b 0.05 vs. WT group, # p b 0.05 vs. WT-CR group.
Fig. 8. Levels of autophagy regulatory cell signalingmoleculesmTOR and ULK1 in hearts from control or caloric restricted (CR)WT and AMPK KDmice. A–B: Total expression ofmTOR and
ULK1; C–D: Phosphorylated form of mTOR and ULK1; and E–F: Ratios of phosphorylated to total forms of mTOR and ULK1. Insets: Representative gel blots depicting total and phosphor-
ylated levels of mTOR and ULK1. GAPDH was used as the loading control. Mean ± SEM, n = 6–7 mice per group, *p b 0.05 vs. WT group, # p b 0.05 vs. WT-CR group.
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The salient ﬁndings from ourwork indicate that AMPK inhibition ac-
centuates prolonged caloric restriction-induced changes in myocardial
geometric and function, as well as intracellular Ca2+ homeostasis (and
intracellular Ca2+ regulatory proteins). Furthermore, our study reveals
that the detrimental effect of AMPK inhibition in the face of prolonged
caloric restriction was related to loss of a compensatory AMPK-TSC-
mTOR-ULK1-associated autophagy regulation in the heart. The AMPK
inhibition-elicited loss of cardiac homeostasis following prolonged calo-
ric restriction is independent of whole body glucose tolerance, body fat
composition, physical activity, blood glucose, insulin and blood pressure
regulation. Taken together, these observations favor the notion that
AMPK is indispensable to the maintenance of myocardial geometry
and function during caloric restriction through a possible compensatory
autophagy regulation.
Data fromour study revealed that prolonged caloric restriction led to
changes in cardiac geometry and function manifested by decreased leftventricularwall thickness, septal thickness, LVEDD, LVmass and cardiac
output. This is supported by altered cardiomyocyte contractile function
(reduced peak shortening and maximal velocity of shortening/
relengthening, prolonged relengthening duration) following prolonged
caloric restriction, consistent with our recent ﬁndings [7,10]. This is also
consistent with the previous ﬁnding that caloric restriction decreases
left ventricular diastolic function in healthy subjects [34]. In our
hands, fractional shortening remains unchanged following caloric re-
striction. The apparentmismatch between cardiac output and fractional
shortening may be due to the contribution of hemodynamic factors
under caloric restriction. Furthermore, our data noted decreased peak
and rise in intracellular Ca2+ in response to electrical-stimuli and
delayed intracellular Ca2+ clearance along with unchanged resting
intracellular Ca2+ following 30-week caloric restriction, indicating a
role of compromised intracellular Ca2+ handling in prolonged caloric
restriction-induced changes in cardiac contractile properties. The
much steeper negative staircase in the stimulus frequency-associated
change in cardiomyocyte contractile capacity following caloric restriction
Fig. 9. Schematic diagram depicting possiblemechanism(s) involved in caloric restriction-
and AMPK deﬁciency-induced changes in cardiac intracellular Ca2+ homeostasis and con-
tractile function. Caloric restriction triggers activation of AMPK. Activation of AMPK pro-
motes TSC complex (through phosphorylation) to impose its inhibition on mTOR-ULK1
signaling through Rheb, leading to facilitated autophagy and autophagy ﬂux. Loss of
AMPK activation in AMPK KD mice interrupts such compensatory autophagy regulation
and cardiac homeostasis under caloric restriction. Arrows denote stimulation whereas
the lines with a “T” ending represent inhibition. AMPK: AMP-activation protein kinase;
TSC: tuber sclerosis complex; mTOR: mammalian target of rapamycin.
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capability following prolonged caloric restriction. Our ﬁndings of
prolonged relaxation duration (TR90) and intracellular Ca2+ decay
time indicate a poor intracellular Ca2+ re-sequestration or Ca2+ cycling
ability, hallmarks of diastolic dysfunction [35–37]. Compromised myo-
cardial diastolic dysfunction has been considered an early sign of dis-
turbed cardiac energy and metabolic balance in cardiac pathological
conditions [3,7,34,37] and was also noted in human subjects following
caloric restriction [34]. Our results of decreased SERCA2a level and
SERCA2a/phospholamban ratio following caloric restriction favor a
key role of compromised intracellular Ca2+ extrusion in the onset and
development of diastolic dysfunction under prolonged caloric restric-
tion. Our data, however, do not favor a major role of Na+–Ca2+ ex-
changer and glut-4 translocation mediator Akt substrate of 160 kD
(AS160) in the impaired intracellular Ca2+ handling under prolonged
caloric restriction. These ﬁndings have helped to consolidate an unfa-
vorable effect of prolonged caloric restriction in cardiac geometry and
contractile function. Furthermore, our data displayed overt autophagy
induction (Atg5, Beclin-1 and LC3BII) in murine hearts associated with
elevated phosphorylation of AMPK, and the AMPK downstream signal-
ingmolecules TSC2 following caloric restriction. Phosphorylation levels
of mTOR and ULK1 were decreased in murine hearts following
sustained caloric restriction. It may be speculated that suppressed
mTOR phosphorylation following caloric restriction may occur second-
ary to elevated phosphorylation of AMPK and TSC, en route to dis-
inhibition of autophagy. Suchmechanismmay serve as a compensatory
regulatory mechanism to maintain cardiac autophagy. ULK1 is known
to be phosphorylated and negatively regulated by mTORC1 [38]. Our
ﬁnding of suppressed ULK1 phosphorylation at Ser757 is in line with
the notion that high mTOR activity suppresses ULK1 activation via
ULK1 phosphorylation at Ser757 to interrupt autophagy induction [38].
Perhaps themost signiﬁcantﬁnding fromour study is that AMPK inhi-
bition accentuated caloric restriction-induced changes in myocardial ge-
ometry and function. Such detrimental effects of AMPK inhibition on
cardiac homeostasis under caloric restriction occurred independent of
whole body glucose tolerance, body fat composition, physical activity,
blood glucose, insulin and blood pressure regulation. Interestingly,
AMPK inhibition completely ﬂipped prolonged caloric restriction-
induced changes in autophagy induction as shown by Beclin-1, Atg5
and LC3B conversion. However, AMPK inhibition did not affect caloric
restriction-induced interruption of autophagy ﬂux as shown by the
autophagosome cargo protein p62. These data denote presence of slowed
autophagosome fusion-degradation following prolonged caloric restric-
tion, the effect of which may be unaffected by AMPK inhibition. These
ﬁndings favor a role of autophagy but unlikely facilitated autophagosome
fusion-degradation in AMPK inhibition-elicited detrimental responses
following prolonged caloric restriction. Our data revealed that AMPK inhi-
bitionmasked orﬂipped prolonged caloric restriction-induced rises in the
phosphorylation of AMPK and TSC2. With higher phosphorylation of
AMPK possibly due to loss of myocardial ATP under caloric restriction as
shown in our study, theAMPK-driven TSC is engaged to allowamore pro-
nounced inhibition of mTOR (through the small GTP binding protein
Rheb) en route to compensatory autophagy induction. The more pro-
nounced mTOR phosphorylation in caloric restricted AMPK KD mice
may contribute to the elevated ULK1 Ser757 phosphorylation. Higher
mTOR activity impedes ULK1 phosphorylation at Ser757 to disturb the in-
teraction between ULK1 and AMPK [38]. These ﬁndings favor a possible
role of the AMPK-TSC-mTOR-ULK1 axis in mediating AMPK inhibition-
induced loss of autophagy under prolonged caloric restriction as depicted
in Fig. 9. It is noteworthy that recent reports from our laboratory sug-
gested that AMPK inhibition may worsen cardiac geometry and function
under fat diet-induced obesity and aging independent of autophagy
regulation [26,27]. Other cellular regulatory machineries should not be
discounted as this time.
In conclusion, the ﬁndings from our present study provide the
evidence for the ﬁrst time that AMPK inhibition worsens myocardialgeometry and function following prolonged caloric restriction. Our
data revealed a pivotal role of the seemingly compensatory autophagy
regulation in cardiac homeostatic responses under caloric restriction.
Under AMPK inhibition, the AMPK driven TSC-Rheb-mTOR-ULK1-
mediated autophagy regulatory cascade may be suppressed to disen-
gage autophagy induction needed in nutrient stress. Although it is still
premature to discern the precise mechanism(s) through which AMPK
inhibition regulates myocardial autophagy in the setting of prolonged
caloric restriction, our study should shed some lights toward a better
understanding for the interplay between the cell fuel AMPK and
autophagy in the maintenance of cardiac homeostasis under nutrient
stress. Although modest calorie restriction in a combined lifestyle
program is likely to improve heart health and prevent subsequent car-
diovascular events in overweight and obese individuals [39], sustained
and excessive caloric restrictionmay perturb energy andmetabolic bal-
ance, resulting in adverse cardiovascular sequelae [40–42]. Further
study is warranted to re-evaluate the cardiac safety issue for caloric
restriction and elucidate the therapeutic value of AMPK activators and
autophagy inducers in the management of cardiac homeostasis under
nutrient deﬁciency.
Acknowledgments
The AMPK KD founder mice were kindly provided by Professor
Morris Birnbaum from the University of Pennsylvania (Philadelphia,
PA, USA) to the University of Wyoming. This work was supported in
part by NSFC (81200102, 30972865, 81270171) and NIH P20 NIGMS
103432.
References
[1] E.P. Weiss, L. Fontana, Caloric restriction: powerful protection for the aging heart
and vasculature, Am. J. Physiol. Heart Circ. Physiol. 301 (2011) H1205–H1219.
[2] V.W. Dolinsky, J.R. Dyck, Calorie restriction and resveratrol in cardiovascular health
and disease, Biochim. Biophys. Acta 1812 (2011) 1477–1489.
[3] X. Han, J. Ren, Caloric restriction and heart function: is there a sensible link? Acta
Pharmacol. Sin. 31 (2010) 1111–1117.
[4] S.R. Spindler, Rapid and reversible induction of the longevity, anticancer and
genomic effects of caloric restriction, Mech. Ageing Dev. 126 (2005) 960–966.
342 Q. Zheng et al. / Biochimica et Biophysica Acta 1852 (2015) 332–342[5] N. Hariharan, Y. Maejima, J. Nakae, J. Paik, R.A. Depinho, J. Sadoshima, Deacetylation
of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy
in cardiac myocytes, Circ. Res. 107 (2010) 1470–1482.
[6] M. Rose, R.M. Greene, Cardiovascular complications during prolonged starvation,
West. J. Med. 130 (1979) 170–177.
[7] X. Han, S. Turdi, N. Hu, R. Guo, Y. Zhang, J. Ren, Inﬂuence of long-term caloric restric-
tion onmyocardial and cardiomyocyte contractile function and autophagy inmice, J.
Nutr. Biochem. 23 (2012) 1592–1599.
[8] N. Mizushima, A. Yamamoto, M. Matsui, T. Yoshimori, Y. Ohsumi, In vivo analysis of
autophagy in response to nutrient starvation using transgenic mice expressing a
ﬂuorescent autophagosome marker, Mol. Biol. Cell 15 (2004) 1101–1111.
[9] H. Kanamori, G. Takemura, R. Maruyama, K. Goto, A. Tsujimoto, A. Ogino, L. Li, I.
Kawamura, T. Takeyama, T. Kawaguchi, K. Nagashima, T. Fujiwara, H. Fujiwara, M.
Seishima, S. Minatoguchi, Functional signiﬁcance and morphological characteriza-
tion of starvation-induced autophagy in the adult heart, Am. J. Pathol. 174 (2009)
1705–1714.
[10] Y. Zhang, X. Han, N. Hu, A.F. Huff, F. Gao, J. Ren, Akt2 knockout alleviates prolonged
caloric restriction-induced change in cardiac contractile function through regulation
of autophagy, J. Mol. Cell. Cardiol. 71 (2014) 81–91.
[11] A.M. Choi, S.W. Ryter, B. Levine, Autophagy in human health and disease, N. Engl. J.
Med. 368 (2013) 651–662.
[12] N. Mizushima, B. Levine, A.M. Cuervo, D.J. Klionsky, Autophagy ﬁghts disease
through cellular self-digestion, Nature 451 (2008) 1069–1075.
[13] S. Nair, J. Ren, Autophagy and cardiovascular aging: lesson learned from rapamycin,
Cell Cycle 11 (2012) 2092–2099.
[14] A. Nemchenko, M. Chiong, A. Turer, S. Lavandero, J.A. Hill, Autophagy as a therapeu-
tic target in cardiovascular disease, J. Mol. Cell. Cardiol. 51 (2011) 584–593.
[15] J.R. McMullen, M.C. Sherwood, O. Tarnavski, L. Zhang, A.L. Dorfman, T. Shioi, S.
Izumo, Inhibition of mTOR signaling with rapamycin regresses established cardiac
hypertrophy induced by pressure overload, Circulation 109 (2004) 3050–3055.
[16] Y. Zhang, J. Ren, Targeting autophagy for the therapeutic application of histone
deacetylase (HDAC) inhibitors in ischemia–reperfusion heart injury, Circulation
129 (2014) 1088–1091.
[17] X. Xu, Y. Hua, S. Nair, R. Bucala, J. Ren, Macrophage migration inhibitory factor
deletion exacerbates pressure overload-induced cardiac hypertrophy through
mitigating autophagy, Hypertension 63 (2014) 490–499.
[18] D.J. Cao, Z.V. Wang, P.K. Battiprolu, N. Jiang, C.R. Morales, Y. Kong, B.A. Rothermel, T.
G. Gillette, J.A. Hill, Histone deacetylase (HDAC) inhibitors attenuate cardiac hyper-
trophy by suppressing autophagy, Proc. Natl. Acad. Sci. U. S. A. 108 (2011)
4123–4128.
[19] Y. Zhang, J. Ren, ALDH2 in alcoholic heart diseases: molecular mechanism and
clinical implications, Pharmacol. Ther. 132 (2011) 86–95.
[20] B. Zhang, Y. Zhang, K.H. La Cour, K.L. Richmond, X.M. Wang, J. Ren, Mitochondrial al-
dehyde dehydrogenase obliterates endoplasmic reticulum stress-induced cardiac
contractile dysfunction via correction of autophagy, Biochim. Biophys. Acta 1832
(2013) 574–584.
[21] B. Levine, D.J. Klionsky, Development by self-digestion: molecular mechanisms and
biological functions of autophagy, Dev. Cell 6 (2004) 463–477.
[22] T. Shintani, D.J. Klionsky, Autophagy in health and disease: a double-edged sword,
Science 306 (2004) 990–995.
[23] A. Salminen, K. Kaarniranta, AMP-activated protein kinase (AMPK) controls the
aging process via an integrated signaling network, Ageing Res. Rev. 11 (2012)
230–241.[24] J. Kim, Y.C. Kim, C. Fang, R.C. Russell, J.H. Kim, W. Fan, R. Liu, Q. Zhong, K.L. Guan,
Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress
and autophagy, Cell 152 (2013) 290–303.
[25] F. McAlpine, L.E. Williamson, S.A. Tooze, E.Y. Chan, Regulation of nutrient-sensitive
autophagy by uncoordinated 51-like kinases 1 and 2, Autophagy 9 (2013) 361–373.
[26] S. Turdi, X. Fan, J. Li, J. Zhao, A.F. Huff, M. Du, J. Ren, AMP-activated protein kinase
deﬁciency exacerbates aging-induced myocardial contractile dysfunction, Aging
Cell 9 (2010) 592–606.
[27] S. Turdi, M.R. Kandadi, J. Zhao, A.F. Huff, M. Du, J. Ren, Deﬁciency in AMP-activated
protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contrac-
tile dysfunction, J. Mol. Cell. Cardiol. 50 (2011) 712–722.
[28] Y. Zhang, M. Yuan, K.M. Bradley, F. Dong, P. Anversa, J. Ren, Insulin-like growth
factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: role of
insulin signaling and mitochondrial function, Hypertension 59 (2012) 680–693.
[29] L. Li, Y. Hua, M. Dong, Q. Li, D.T. Smith, M. Yuan, K.R. Jones, J. Ren, Short-term
lenalidomide (Revlimid) administration ameliorates cardiomyocyte contractile
dysfunction in ob/ob obese mice, Obesity (Silver Spring) 20 (2012) 2174–2185.
[30] R. Guo, Y. Zhang, S. Turdi, J. Ren, Adiponectin knockout accentuates high fat diet-
induced obesity and cardiac dysfunction: Role of autophagy, Biochim. Biophys.
Acta 1832 (2013) 1136–1148.
[31] Y. Kabeya, N. Mizushima, T. Ueno, A. Yamamoto, T. Kirisako, T. Noda, E. Kominami, Y.
Ohsumi, T. Yoshimori, LC3, a mammalian homologue of yeast Apg8p, is localized in
autophagosome membranes after processing, EMBO J. 19 (2000) 5720–5728.
[32] G. Bjorkoy, T. Lamark, A. Brech, H. Outzen, M. Perander, A. Overvatn, H. Stenmark, T.
Johansen, p62/SQSTM1 forms protein aggregates degraded by autophagy and has a
protective effect on huntingtin-induced cell death, J. Cell Biol. 171 (2005) 603–614.
[33] C. Pohl, S. Jentsch, Midbody ring disposal by autophagy is a post-abscission event of
cytokinesis, Nat. Cell Biol. 11 (2009) 65–70.
[34] R.W. van der Meer, S. Hammer, J.W. Smit, M. Frolich, J.J. Bax, M. Diamant, L.J.
Rijzewijk, A. de Roos, J.A. Romijn, H.J. Lamb, Short-term caloric restriction induces
accumulation of myocardial triglycerides and decreases left ventricular diastolic
function in healthy subjects, Diabetes 56 (2007) 2849–2853.
[35] J. Ren, L. Pulakat, A. Whaley-Connell, J.R. Sowers, Mitochondrial biogenesis in the
metabolic syndrome and cardiovascular disease, J. Mol. Med. (Berl.) 88 (2010)
993–1001.
[36] D.M. Bers, Cardiac sarcoplasmic reticulum calcium leak: basis and roles in cardiac
dysfunction, Annu. Rev. Physiol. 76 (2014) 107–127.
[37] M. Kohlhaas, C. Maack, Interplay of defective excitation–contraction coupling,
energy starvation, and oxidative stress in heart failure, Trends Cardiovasc. Med. 21
(2011) 69–73.
[38] J. Kim, M. Kundu, B. Viollet, K.L. Guan, AMPK andmTOR regulate autophagy through
direct phosphorylation of Ulk1, Nat. Cell Biol. 13 (2011) 132–141.
[39] C.W. Bales, W.E. Kraus, Caloric restriction: implications for human cardiometabolic
health, J. Cardiopulm. Rehabil. Prev. 33 (2013) 201–208.
[40] M.F. Dutra, I.J. Bristot, C. Batassini, N.B. Cunha, A.F. Vizuete, D.F. de Souza, J.C.
Moreira, C.A. Goncalves, Effects of chronic caloric restriction on kidney and heart
redox status and antioxidant enzyme activities in Wistar rats, BMB Rep. 45 (2012)
671–676.
[41] K. Chen, S. Kobayashi, X. Xu, B. Viollet, Q. Liang, AMP activated protein kinase is in-
dispensable for myocardial adaptation to caloric restriction in mice, PLoS One 8
(2013) e59682.
[42] Counting calories to keep your heart young. New research ﬁnds it effective, but is it
safe? Harvard health letter/from Harvard Medical School, 37, 2012, p. 3.
